Semnur Pharmaceuticals, Inc.
SMNR
$0.55
-$0.01-1.79%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -167.68M | -164.33M | -160.42M | -155.03M | -3.74M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 145.13M | 143.83M | 142.44M | 140.54M | 500.00K |
| Change in Net Operating Assets | 12.01M | 12.36M | 12.11M | 10.83M | 1.28M |
| Cash from Operations | -10.54M | -8.14M | -5.87M | -3.67M | -1.96M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 9.56M | 8.12M | 5.85M | 7.74M | 4.36M |
| Total Debt Repaid | -1.41M | -750.00K | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.38M | 863.00K | 27.00K | -4.00M | -2.35M |
| Cash from Financing | 10.53M | 8.23M | 5.88M | 3.74M | 2.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.00K | 96.00K | 8.00K | 72.00K | 40.00K |